| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.09 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |